Scribe Therapeutics Inc. Common Stock (SCTX) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · United States · ISIN US8110331092
Scribe Therapeutics Inc. Common Stock financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 27.41 m USD | 51.17 m USD |
| Operating income | -42.83 m USD | -26.07 m USD |
| EBIT | -35.18 m USD | -21.22 m USD |
| Net income | -47.79 m USD | -21.81 m USD |
| Diluted EPS – continuing operations | -2.72 USD | -1.24 USD |
Full history since 2024, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Scribe Therapeutics Inc. Common Stock
Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on cardiometabolic conditions in the United States. The company offers STX-1150 designed to be a single-course in vivo epigenetic silencing treatment targeting the PCSK9 gene; STX-1200 is CRISPR-based gene editing program that aims to offer a permanent solution for patients with elevated Lp(a); and STX-1400 is designed to target and remove the transcriptional start site of the APOC3 gene and strongly reduce mRNA expression. It uses CRISPR-based platforms, such as ELXR, designed for precise, durable epigenetic silencing of genes without changing the underlying DNA sequence; and XE, designed to support specific and efficient gene editing. The company was incorporated in 2017 and is headquartered in Alameda, California.
More stocks
- FVCBankcorp, Inc. (FVCB)
- Belo Sun Mining Corp. (BSX.TO)
- Il Dong Pharmaceutical Co Ltd (249420.KS)
- Rainbow Chicken Limited (RBO.JO)
- VT Industrial Technology Co Ltd (300707.SZ)
- Kenmare Resources PLC (KMR.IR)
- Jiang Su New Technology Co. Ltd. (301229.SZ)
- Ajinomoto Malaysia Bhd (2658.KL)
- FocalTech Systems Co Ltd (3545.TW)
- Iron Horse Acquisition II Corp. (IRHO)
- Dongwon Systems Corp (014825.KS)
- Formycon (FYB.DE)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.